A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
复制标题
DOI：
10.1002/lt.20526
复制
发表时间：
2005-12-01
影响因子：
4.6
通讯作者：
Robert, JP
中科院分区：
文献类型：
--
作者：
Yao, FY;Hirose, R;Robert, JP
在肝细胞癌（HCC）患者中，超过常规（T2）标准的原位肝移植（奥尔特），局部区域治疗的可行性和结果旨在肿瘤降级，以满足奥尔特的T2标准是未知的。在第一个关于肝细胞癌肝奥尔特前降级的前瞻性研究中，纳入降级方案的合格标准包括1个病变>5 cm和3 cm，但
In patients with hepatocellular carcinoma (HCC) exceeding conventional (T2) criteria for orthotopic liver transplantation (OLT), the feasibility and outcome following loco-regional therapy intended for tumor downstaging to meet T2 criteria for OLT are unknown. In this first prospective study on downstaging of HCC prior to OLT, the eligibility criteria for enrollment into a downstaging protocol included 1 lesion >5 cm and 3 cm but